DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1Dr.Reddy's Laboratories Limited
02 1Catalent Micron Technologies, Inc.
03 1Hetero Labs Limited
04 1Jiangsu Hengrui Pharmaceuticals Co., Ltd.
05 2Natco Pharma Limited
06 1SUN PHARMACEUTICAL INDUSTRIES, INC.
07 1ScinoPharm Taiwan Ltd.
08 1Sicor de Mexico S.A. de C.V
09 1Synthimed Labs Private Limited
01 9Letrozole
02 1letrozole
01 1China
02 6India
03 1Mexico
04 1Taiwan
05 1U.S.A
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
NDC Package Code : 55111-809
Start Marketing Date : 2007-11-13
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 69988-0014
Start Marketing Date : 2006-05-01
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/1)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 68554-0039
Start Marketing Date : 1997-07-25
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 57884-0011
Start Marketing Date : 2012-05-07
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 63850-7723
Start Marketing Date : 2016-01-19
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 63850-7701
Start Marketing Date : 2016-01-12
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65129-1130
Start Marketing Date : 2005-07-04
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 63592-3376
Start Marketing Date : 2018-10-19
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (100kg/100kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 62756-235
Start Marketing Date : 2021-01-15
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65096-0116
Start Marketing Date : 2018-08-31
End Marketing Date : 2027-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
78
PharmaCompass offers a list of Letrozole API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Letrozole manufacturer or Letrozole supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Letrozole manufacturer or Letrozole supplier.
A Novartis Brand of Letrozole manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Novartis Brand of Letrozole, including repackagers and relabelers. The FDA regulates Novartis Brand of Letrozole manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Novartis Brand of Letrozole API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Novartis Brand of Letrozole manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Novartis Brand of Letrozole supplier is an individual or a company that provides Novartis Brand of Letrozole active pharmaceutical ingredient (API) or Novartis Brand of Letrozole finished formulations upon request. The Novartis Brand of Letrozole suppliers may include Novartis Brand of Letrozole API manufacturers, exporters, distributors and traders.
click here to find a list of Novartis Brand of Letrozole suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Novartis Brand of Letrozole as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Novartis Brand of Letrozole API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Novartis Brand of Letrozole as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Novartis Brand of Letrozole and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Novartis Brand of Letrozole NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Novartis Brand of Letrozole suppliers with NDC on PharmaCompass.
We have 9 companies offering Novartis Brand of Letrozole
Get in contact with the supplier of your choice:
